Adaptimmune Therapeutics plc ADAP

$ 0.66 3.86%

Quarterly report 2024-Q3
added 11-13-2024

Adaptimmune Therapeutics plc EV/EBITDA Ratio 2011-2024 | ADAP

Annual EV/EBITDA Ratio Adaptimmune Therapeutics plc

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-12.7	-6.44	-19.1 K	-36.5 K	-60.8 K	-25.6 K	-343	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-6.44	-60.8 K	-20.3 K